Skip to main content
Top
Published in: International Urology and Nephrology 8/2015

01-08-2015 | Nephrology - Original Paper

Visceral adiposity index, hypertriglyceridemic waist phenotype and chronic kidney disease in a southern Chinese population: a cross-sectional study

Authors: Jun Huang, Chaomin Zhou, Yongqiang Li, Shuangshuang Zhu, Aiqun Liu, Xiaofei Shao, Xinyu Liu, Harry Holthfer, Hequn Zou

Published in: International Urology and Nephrology | Issue 8/2015

Login to get access

Abstract

Objective

To explore the relationships between visceral adiposity index (VAI), hypertriglyceridemic waist phenotype (HW phenotype) and chronic kidney disease (CKD).

Methods

A cross-sectional study was conducted in Zhuhai City June–October 2012. A total of 2142 participants were recruited. Logistic regression was used to evaluate the associations between VAI, HW phenotype and CKD.

Results

After adjustment for age, VAI was significantly associated with CKD (OR 2.16, 95 % CI 1.25–3.74, P = 0.006) in women. Further adjusted for potential confounders, the association was still significant in women (OR 2.07, 95 % CI 1.17–3.64, P = 0.01). However, the association was abolished when adding diabetes and hypertension to the model (OR 1.68, 95 % CI 0.92–3.06, P = 0.09). The age-adjusted OR (95 % CI, P) of CKD associated with HW phenotype was 2.21 (1.29–3.76, 0.004) and 2.54 (1.53–4.22, <0.001) for men and women, respectively. Further adjusted for potential confounders, the associations were still significant in both subgroups. The OR for CKD was 2.41 (95 % CI 1.42–4.12, P = 0.001) and 2.32 (95 % CI 1.31–4.11, P = 0.004) for women and men, respectively. When further adjusted for diabetes and hypertension, the association of HW phenotype and CKD was significant (OR 1.88, 95 % CI 1.05–3.36, P = 0.033) in women. However, the model is abolished in men (OR 1.50, 95 % CI 0.81–2.78, P = 0.19).

Conclusion

Our results suggest that both VAI and the HW phenotype might be useful clinical indicators of CKD in China for females but not for males. The HW phenotype associated more strongly with CKD, compared with VAI.
Literature
1.
go back to reference Zhang L, Wang F, Wang L, Wang W, Liu B et al (2012) Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet 379:815–822PubMedCrossRef Zhang L, Wang F, Wang L, Wang W, Liu B et al (2012) Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet 379:815–822PubMedCrossRef
2.
go back to reference Zhang L, Wang H (2009) Chronic kidney disease epidemic: cost and health care implications in China. Semin Nephrol 29:483–486PubMedCrossRef Zhang L, Wang H (2009) Chronic kidney disease epidemic: cost and health care implications in China. Semin Nephrol 29:483–486PubMedCrossRef
3.
go back to reference Wang H, Zhang L, Lv J (2005) Prevention of the progression of chronic kidney disease: practice in China. Kidney Int Suppl 67:S63–S67CrossRef Wang H, Zhang L, Lv J (2005) Prevention of the progression of chronic kidney disease: practice in China. Kidney Int Suppl 67:S63–S67CrossRef
4.
go back to reference Ayodele OE, Alebiosu CO (2010) Burden of chronic kidney disease: an international perspective. Adv Chronic Kidney Dis 17:215–224PubMedCrossRef Ayodele OE, Alebiosu CO (2010) Burden of chronic kidney disease: an international perspective. Adv Chronic Kidney Dis 17:215–224PubMedCrossRef
5.
go back to reference Schieppati Arrigo, Remuzzi Giuseppe (2005) Chronic renal diseases as a public health problem: epidemiology, social, and economic implications. Kidney Int 68:S7–S10CrossRef Schieppati Arrigo, Remuzzi Giuseppe (2005) Chronic renal diseases as a public health problem: epidemiology, social, and economic implications. Kidney Int 68:S7–S10CrossRef
6.
go back to reference Eknoyan G, Lameire N, Barsoum R, Eckardt KU, Levin A et al (2004) The burden of kidney disease: improving global outcomes. Kidney Int 66:1310–1314PubMedCrossRef Eknoyan G, Lameire N, Barsoum R, Eckardt KU, Levin A et al (2004) The burden of kidney disease: improving global outcomes. Kidney Int 66:1310–1314PubMedCrossRef
7.
go back to reference Hall JE, Henegar JR, Dwyer TM, Liu J, da Silva AA et al (2004) Is obesity a major cause of chronic kidney disease? Adv Ren Replace Ther 11:41–54PubMedCrossRef Hall JE, Henegar JR, Dwyer TM, Liu J, da Silva AA et al (2004) Is obesity a major cause of chronic kidney disease? Adv Ren Replace Ther 11:41–54PubMedCrossRef
8.
go back to reference Navaneethan SD, Kirwan JP, Arrigain S, Schreiber MJ, Sehgal AR et al (2012) Overweight, obesity and intentional weight loss in chronic kidney disease: nHANES 1999–2006. Int J Obes (Lond) 36:1585–1590CrossRef Navaneethan SD, Kirwan JP, Arrigain S, Schreiber MJ, Sehgal AR et al (2012) Overweight, obesity and intentional weight loss in chronic kidney disease: nHANES 1999–2006. Int J Obes (Lond) 36:1585–1590CrossRef
9.
go back to reference Pinto-Sietsma S-J, Navis G, Janssen WM, de Zeeuw D, Gans RO et al (2003) A central body fat distribution is related to renal function impairment, even in lean subjects. Am J Kidney Dis 41:733–741PubMedCrossRef Pinto-Sietsma S-J, Navis G, Janssen WM, de Zeeuw D, Gans RO et al (2003) A central body fat distribution is related to renal function impairment, even in lean subjects. Am J Kidney Dis 41:733–741PubMedCrossRef
10.
go back to reference Kim SR, Yoo JH, Song HC, Lee SS, Yoo SJ et al (2011) Relationship of visceral and subcutaneous adiposity with renal function in people with type 2 diabetes mellitus. Nephrol Dial Transplant 26:3550–3555PubMedCrossRef Kim SR, Yoo JH, Song HC, Lee SS, Yoo SJ et al (2011) Relationship of visceral and subcutaneous adiposity with renal function in people with type 2 diabetes mellitus. Nephrol Dial Transplant 26:3550–3555PubMedCrossRef
11.
go back to reference Lemieux I, Alme´ras N, Mauriege P, Blanchet C, Dewailly E et al (2002) Prevalence of hypertriglyceridemic waist in men who participated in the Quebec Health Survey: association with atherogenic and diabetogenic metabolic risk factors. Can J Cardiol 18:725–732PubMed Lemieux I, Alme´ras N, Mauriege P, Blanchet C, Dewailly E et al (2002) Prevalence of hypertriglyceridemic waist in men who participated in the Quebec Health Survey: association with atherogenic and diabetogenic metabolic risk factors. Can J Cardiol 18:725–732PubMed
12.
go back to reference Ross R, Aru J, Freeman J, Hudson R, Janssen I (2002) Abdominal adiposity and insulin resistance in obese men. Am J Physiol Endocrinol Metab 282:E657–E663PubMedCrossRef Ross R, Aru J, Freeman J, Hudson R, Janssen I (2002) Abdominal adiposity and insulin resistance in obese men. Am J Physiol Endocrinol Metab 282:E657–E663PubMedCrossRef
13.
go back to reference Ross R, Freeman J, Hudson R, Janssen I (2002) Abdominal obesity, muscle composition, and insulin resistance in premenopausal women. J Clin Endocrinol Metab 87:5044–5051PubMedCrossRef Ross R, Freeman J, Hudson R, Janssen I (2002) Abdominal obesity, muscle composition, and insulin resistance in premenopausal women. J Clin Endocrinol Metab 87:5044–5051PubMedCrossRef
15.
go back to reference Li Y, Zhao L, Chen Y, Liu A, Liu X et al (2013) Association between metabolic syndrome and chronic kidney disease in perimenopausal women. Int J Environ Res Public Health 10:3987–3997PubMedCentralPubMedCrossRef Li Y, Zhao L, Chen Y, Liu A, Liu X et al (2013) Association between metabolic syndrome and chronic kidney disease in perimenopausal women. Int J Environ Res Public Health 10:3987–3997PubMedCentralPubMedCrossRef
16.
go back to reference Li Y, Zhou C, Shao X, Liu X, Guo J et al (2014) Hypertriglyceridemic waist phenotype and chronic kidney disease in a Chinese population aged 40 years and older. PLoS ONE 9:e92322PubMedCentralPubMedCrossRef Li Y, Zhou C, Shao X, Liu X, Guo J et al (2014) Hypertriglyceridemic waist phenotype and chronic kidney disease in a Chinese population aged 40 years and older. PLoS ONE 9:e92322PubMedCentralPubMedCrossRef
17.
go back to reference Li Y, Chen Y, Liu X, Liang Y, Shao X et al (2014) Metabolic syndrome and chronic kidney disease in a Southern Chinese population. Nephrology (Carlton) 19:325–331CrossRef Li Y, Chen Y, Liu X, Liang Y, Shao X et al (2014) Metabolic syndrome and chronic kidney disease in a Southern Chinese population. Nephrology (Carlton) 19:325–331CrossRef
18.
go back to reference Knapp M, Hadid O (1987) Investigations into negative interference by jaundiced plasma in kinetic Jaffé methods for plasma creatinine determination. Ann Clin Biochem 24:85PubMedCrossRef Knapp M, Hadid O (1987) Investigations into negative interference by jaundiced plasma in kinetic Jaffé methods for plasma creatinine determination. Ann Clin Biochem 24:85PubMedCrossRef
19.
go back to reference Amato MC, Giordano C, Galia M, Criscimanna A, Vitabile S et al (2010) Visceral adiposity index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care 33:920–922PubMedCentralPubMedCrossRef Amato MC, Giordano C, Galia M, Criscimanna A, Vitabile S et al (2010) Visceral adiposity index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care 33:920–922PubMedCentralPubMedCrossRef
20.
go back to reference Du T, Sun X, Huo R, Yu X (2013) Visceral adiposity index, hypertriglyceridemic waist and risk of diabetes: the China Health and Nutrition Survey 2009. Int J Obes. doi:10.1038/ijo.2013.181 Du T, Sun X, Huo R, Yu X (2013) Visceral adiposity index, hypertriglyceridemic waist and risk of diabetes: the China Health and Nutrition Survey 2009. Int J Obes. doi:10.​1038/​ijo.​2013.​181
21.
go back to reference Ma Y-C, Zuo L, Chen J-H, Luo Q, Yu X-Q et al (2006) Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol 17:2937–2944PubMedCrossRef Ma Y-C, Zuo L, Chen J-H, Luo Q, Yu X-Q et al (2006) Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol 17:2937–2944PubMedCrossRef
22.
go back to reference Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH et al (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112(17):2735–2752PubMedCrossRef Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH et al (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112(17):2735–2752PubMedCrossRef
23.
go back to reference Ng A, Wai D, Tai E, Ng K, Chan L (2012) Visceral adipose tissue, but not waist circumference is a better measure of metabolic risk in Singaporean Chinese and Indian men. Nutr Diabetes 2:e38PubMedCentralPubMedCrossRef Ng A, Wai D, Tai E, Ng K, Chan L (2012) Visceral adipose tissue, but not waist circumference is a better measure of metabolic risk in Singaporean Chinese and Indian men. Nutr Diabetes 2:e38PubMedCentralPubMedCrossRef
24.
go back to reference Cornier MA, Despres JP, Davis N, Grossniklaus DA, Klein S et al (2011) Assessing adiposity: a scientific statement from the American Heart Association. Circulation 124:1996–2019PubMedCrossRef Cornier MA, Despres JP, Davis N, Grossniklaus DA, Klein S et al (2011) Assessing adiposity: a scientific statement from the American Heart Association. Circulation 124:1996–2019PubMedCrossRef
25.
go back to reference Oh J-Y, Sung Y-A, Lee HJ (2013) The visceral adiposity index as a predictor of insulin resistance in young women with polycystic ovary syndrome. Obesity (Silver Spring, Md) 21:1690–1694CrossRef Oh J-Y, Sung Y-A, Lee HJ (2013) The visceral adiposity index as a predictor of insulin resistance in young women with polycystic ovary syndrome. Obesity (Silver Spring, Md) 21:1690–1694CrossRef
26.
go back to reference Kahn HS, Cheng YJ (2008) Longitudinal changes in BMI and in an index estimating excess lipids among white and black adults in the United States. Int J Obes (Lond) 32:136–143CrossRef Kahn HS, Cheng YJ (2008) Longitudinal changes in BMI and in an index estimating excess lipids among white and black adults in the United States. Int J Obes (Lond) 32:136–143CrossRef
27.
go back to reference Lemieux I, Pascot A, Couillard C, Lamarche B, Tchernof A et al (2000) Hypertriglyceridemic waist: a marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? Circulation 102:179–184PubMedCrossRef Lemieux I, Pascot A, Couillard C, Lamarche B, Tchernof A et al (2000) Hypertriglyceridemic waist: a marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? Circulation 102:179–184PubMedCrossRef
28.
go back to reference LaMonte MJ, Ainsworth BE, DuBose KD, Grandjean PW, Davis PG et al (2003) The hypertriglyceridemic waist phenotype among women. Atherosclerosis 171:123–130PubMedCrossRef LaMonte MJ, Ainsworth BE, DuBose KD, Grandjean PW, Davis PG et al (2003) The hypertriglyceridemic waist phenotype among women. Atherosclerosis 171:123–130PubMedCrossRef
29.
go back to reference Arsenault BJ, Lemieux I, Despres J-P, Wareham NJ, Kastelein JJP et al (2010) The hypertriglyceridemic-waist phenotype and the risk of coronary artery disease: results from the EPIC-Norfolk prospective population study. CMAJ 182:1427–1432PubMedCentralPubMedCrossRef Arsenault BJ, Lemieux I, Despres J-P, Wareham NJ, Kastelein JJP et al (2010) The hypertriglyceridemic-waist phenotype and the risk of coronary artery disease: results from the EPIC-Norfolk prospective population study. CMAJ 182:1427–1432PubMedCentralPubMedCrossRef
30.
go back to reference Lemieux I, Almeras N, Mauriege P, Blanchet C, Dewailly E et al (2002) Prevalence of ‘hypertriglyceridemic waist’ in men who participated in the Quebec Health Survey: association with atherogenic and diabetogenic metabolic risk factors. Can J Cardiol 18:725–732PubMed Lemieux I, Almeras N, Mauriege P, Blanchet C, Dewailly E et al (2002) Prevalence of ‘hypertriglyceridemic waist’ in men who participated in the Quebec Health Survey: association with atherogenic and diabetogenic metabolic risk factors. Can J Cardiol 18:725–732PubMed
31.
go back to reference Després J-P, Lemieux I, Bergeron J, Pibarot P, Mathieu P et al (2008) Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol 28:1039–1049PubMedCrossRef Després J-P, Lemieux I, Bergeron J, Pibarot P, Mathieu P et al (2008) Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol 28:1039–1049PubMedCrossRef
33.
go back to reference Kwakernaak AJ, Zelle DM, Bakker SJ, Navis G (2013) Central body fat distribution associates with unfavorable renal hemodynamics independent of body mass index. J Am Soc Nephrol 24:987–994PubMedCentralPubMedCrossRef Kwakernaak AJ, Zelle DM, Bakker SJ, Navis G (2013) Central body fat distribution associates with unfavorable renal hemodynamics independent of body mass index. J Am Soc Nephrol 24:987–994PubMedCentralPubMedCrossRef
34.
go back to reference Roubicek T, Bartlova M, Krajickova J, Haluzikova D, Mraz M et al (2009) Increased production of proinflammatory cytokines in adipose tissue of patients with end-stage renal disease. Nutrition 25(7–8):762–768PubMedCrossRef Roubicek T, Bartlova M, Krajickova J, Haluzikova D, Mraz M et al (2009) Increased production of proinflammatory cytokines in adipose tissue of patients with end-stage renal disease. Nutrition 25(7–8):762–768PubMedCrossRef
35.
go back to reference Shively CA, Register TC, Clarkson TB (2009) Social stress, visceral obesity, and coronary artery atherosclerosis: product of a primate adaptation. Am J Primatol 71(9):742–751PubMedCentralPubMedCrossRef Shively CA, Register TC, Clarkson TB (2009) Social stress, visceral obesity, and coronary artery atherosclerosis: product of a primate adaptation. Am J Primatol 71(9):742–751PubMedCentralPubMedCrossRef
Metadata
Title
Visceral adiposity index, hypertriglyceridemic waist phenotype and chronic kidney disease in a southern Chinese population: a cross-sectional study
Authors
Jun Huang
Chaomin Zhou
Yongqiang Li
Shuangshuang Zhu
Aiqun Liu
Xiaofei Shao
Xinyu Liu
Harry Holthfer
Hequn Zou
Publication date
01-08-2015
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 8/2015
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-015-1040-y

Other articles of this Issue 8/2015

International Urology and Nephrology 8/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.